Dominguez Bastante M, Molina Raya A, Vilchez Rabelo A, Villar Del Moral J, Exposito Ruiz M, Fundora Suarez Y
General Surgery and Liver Transplantation Unit, University Hospital Virgen de las Nieves, Granada, Spain.
General Surgery and Liver Transplantation Unit, University Hospital Virgen de las Nieves, Granada, Spain.
Transplant Proc. 2018 Mar;50(2):628-630. doi: 10.1016/j.transproceed.2017.11.062.
Liver transplantation offers patients with terminal liver disease an effective treatment accompanied by excellent quality of life, but it also has complications, such as hepatic artery thrombosis and development of ischemic cholangiopathy, described in 3%-17% of patients. It is a very important cause of morbidity and mortality. The objective of this report was to analyze the efficacy of the treatment they received in relation to the development of ischemic cholangiopathy and a comparative survival analysis and to propose prophylactic measures for high-risk patients.
肝移植为终末期肝病患者提供了一种有效的治疗方法，且患者生活质量良好，但它也存在一些并发症，如肝动脉血栓形成和缺血性胆管病的发生，在3% - 17%的患者中有所描述。这是发病和死亡的一个非常重要的原因。本报告的目的是分析他们所接受的治疗对于缺血性胆管病发生的疗效以及进行生存比较分析，并为高危患者提出预防措施。
